Literature DB >> 27940056

Terpenoids as anti-colon cancer agents - A comprehensive review on its mechanistic perspectives.

Sharada H Sharma1, Senthilkumar Thulasingam1, Sangeetha Nagarajan2.   

Abstract

Multistep model of colon carcinogenesis has provided the framework to advance our understanding of the molecular basis of colon cancer. This multistage process of carcinogenesis takes a long period to transform from a normal epithelial cell to invasive carcinoma. Thus, it provides enough time to intervene the process of carcinogenesis especially through dietary modification. In spite of the in-depth understanding of the colon cancer etiology and pathophysiology and its association with diet, colon cancer remains a major cause of cancer mortality worldwide. Phytochemicals and their derivatives are gaining attention in cancer prevention and treatment strategies because of cancer chemotherapy associated adverse effects. Being the largest group of phytochemicals traditionally used for medicinal purpose in India and China, terpenoids are recently being explored as anticancer agents. Anticancer properties of terpenoids are associated with various mechanisms like counteraction of oxidative stress, potentiating endogenous antioxidants, improving detoxification potential, disrupting cell survival pathways and inducing apoptosis. This review gives a comprehensive idea of naturally occurring terpenoids as useful agents for the prevention of colon cancer with reference to their classes, sources and molecular targets. Based on the explored molecular targets further research in colon cancer chemoprevention is warranted.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon cancer prevention; Molecular targets; Oncogenesis; Signaling pathways; Terpenoids

Mesh:

Substances:

Year:  2016        PMID: 27940056     DOI: 10.1016/j.ejphar.2016.12.008

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.

Authors:  Xiao-Yan Jin; Hao Chen; Dong-Dong Li; A-Liang Li; Wen-Yan Wang; Wen Gu
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Marine-Derived Penicillium purpurogenum Reduces Tumor Size and Ameliorates Inflammation in an Erlich Mice Model.

Authors:  Amanda Mara Teles; Leticia Prince Pereira Pontes; Sulayne Janayna Araújo Guimarães; Ana Luiza Butarelli; Gabriel Xavier Silva; Flavia Raquel Fernandes do Nascimento; Geusa Felipa de Barros Bezerra; Carla Junqueira Moragas-Tellis; Rui Miguel Gil da Costa; Marcos Antonio Custódio Neto da Silva; Fernando Almeida-Souza; Kátia da Silva Calabrese; Ana Paula Silva Azevedo-Santos; Maria do Desterro Soares Brandão Nascimento
Journal:  Mar Drugs       Date:  2020-10-29       Impact factor: 5.118

Review 3.  Fermentation Strategies for Production of Pharmaceutical Terpenoids in Engineered Yeast.

Authors:  Erdem Carsanba; Manuela Pintado; Carla Oliveira
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26

4.  Knockdown of OLR1 weakens glycolytic metabolism to repress colon cancer cell proliferation and chemoresistance by downregulating SULT2B1 via c-MYC.

Authors:  Tiancheng Zhao; Yezhou Li; Kexin Shen; Quan Wang; Jiayu Zhang
Journal:  Cell Death Dis       Date:  2021-12-17       Impact factor: 8.469

Review 5.  Whole-Genome Sequencing and Comparative Genomics Analysis of the Wild Edible Mushroom (Gomphus purpuraceus) Provide Insights into Its Potential Food Application and Artificial Domestication.

Authors:  Yangyang Geng; Shixin Zhang; Ningxian Yang; Likang Qin
Journal:  Genes (Basel)       Date:  2022-09-10       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.